Caricamento...

Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer

BACKGROUND: Improved methods are needed for predicting prognosis and the benefit of delivering adjuvant chemotherapy (ACT) in patients with non-small-cell lung cancer (NSCLC). METHODS: A novel prognostic algorithm was identified using genomic profiles from 332 stage I-III adenocarcinomas and indepen...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autore principale: Van Laar, Ryan K
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2012
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3407714/
https://ncbi.nlm.nih.gov/pubmed/22748043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-8794-5-30
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !